Metabolomic approaches in the study of wine benefits in human health

Wine Safety, Consumer Preference, and Human Health

Volumn , Issue , 2016, Pages 293-317

  Khymenets, Olha ^a,b   Vázquez Fresno, Rosa ^a,b   Palau Rodriguez, Magali ^a,b   Llorach, Rafael ^a,b   Urpí Sardà, Mireia ^a,b   Garcia Aloy, Mar ^a,b   Tulipani, Sara ^c   Lupianez Barbero, Ascensión ^a,b   Andres Lacueva, Cristina ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Ministry of Science and Innovation   (Spain)

^c Hospital Complex Virgen de la Victoria   (Spain)

Author keywords

Biomarker of consumption; Biomarker of effect; Combined biomarkers; Wine biomarkers

Indexed keywords

EID: 85008950095     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-24514-0_15     Document Type: Chapter

References (68)

1. Andres-Lacueva C, Urpi-Sarda M, Zamora-Ros R, Lamuela-Raventos RM. Bioavailability and metabolism of resveratrol. Plant phenolics and human health. New York, NY: John Wiley & Sons; 2009. p. 265-97. doi: 10.1002/9780470531792.ch13.
2. Astarita G, Langridge J. An emerging role for metabolomics in nutrition science. J Nutrigenet Nutrigenomics. 2013;6(4-5): 181-200. doi: 10.1159/000354403.
3. Barroso E, Sanchez-Patan F, Martin-Alvarez PJ, Bartolome B, Moreno-Arribas MV, Pelaez C, Requena T, van de Wiele T, Martinez-Cuesta MC. Lactobacillus plantarum IFPL935 favors the initial metabolism of red wine polyphenols when added to a colonic microbiota. J Agric Food Chem. 2013;61(42): 10163-72. doi: 10.1021/jf402816r.
4. Batch BC, Hyland K, Svetkey LP. Branch chain amino acids: biomarkers of health and disease. Curr Opin Clin Nutr Metab Care. 2014;17(1): 86-9. doi: 10.1097/MCO.0000000000000010.
5. Bode LM, Bunzel D, Huch M, Cho GS, Ruhland D, Bunzel M, Bub A, Franz CM, Kulling SE. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am J Clin Nutr. 2013;97(2): 295-309. doi: 10.3945/ajcn.112.049379.
6. Bolca S, Van de Wiele T, Possemiers S. Gut metabotypes govern health effects of dietary polyphenols. Curr Opin Biotechnol. 2013;24(2): 220-5. doi: 10.1016/j.copbio.2012.09.009.
7. Boto-Ordonez M, Urpi-Sarda M, Queipo-Ortuno MI, Corella D, Tinahones FJ, Estruch R, Andres-Lacueva C. Microbial metabolomic fingerprinting in urine after regular dealcoholized red wine consumption in humans. J Agric Food Chem. 2013;61(38): 9166-75. doi: 10.1021/jf402394c.
8. Boto-Ordonez M, Urpi-Sarda M, Queipo-Ortuno MI, Tulipani S, Tinahones FJ, Andres-Lacueva C. High levels of Bifidobacteria are associated with increased levels of anthocyanin microbial metabolites: a randomized clinical trial. Food Funct. 2014;5: 1932-40. doi: 10.1039/c4fo00029c.
9. Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS. The human urine metabolome. PLoS One. 2013;8(9), e73076. doi: 10.1371/journal.pone.0073076.
10. Brennan L. Metabolomics in nutrition research: current status and perspectives. Biochem Soc Trans. 2013;41(2): 670-3. doi: 10.1042/BST20120350.
11. Burton L, Ivosev G, Tate S, Impey G, Wingate J, Bonner R. Instrumental and experimental effects in LC-MS-based metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;871(2): 227-35. doi: 10.1016/j.jchromb.2008.04.044.
12. Cardona F, Andres-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuno MI. Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem. 2013;24(8): 1415-22. doi: 10.1016/j.jnutbio.2013.05.001.
13. Chiva-Blanch G, Arranz S, Lamuela-Raventos RM, Estruch R. Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies. Alcohol Alcohol. 2013;48(3): 270-7. doi: 10.1093/alcalc/agt007.
14. Clemente-Postigo M, Queipo-Ortuno MI, Boto-Ordonez M, Coin-Araguez L, Roca-Rodriguez MM, Delgado-Lista J, Cardona F, Andres-Lacueva C, Tinahones FJ. Effect of acute and chronic red wine consumption on lipopolysaccharide concentrations. Am J Clin Nutr. 2013;97(5): 1053-61. doi: 10.3945/ajcn.112.051128.
15. Delmas D, Aires V, Limagne E, Dutartre P, Mazue F, Ghiringhelli F, Latruffe N. Transport, stability, and biological activity of resveratrol. Ann N Y Acad Sci. 2011;1215: 48-59. doi: 10.1111/j.1749-6632.2010.05871.x.
16. Etxeberria U, Fernandez-Quintela A, Milagro FI, Aguirre L, Martinez JA, Portillo MP. Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J Agric Food Chem. 2013;61(40): 9517-33. doi: 10.1021/jf402506c.
17. Fernández-Peralbo MA, Luque de Castro MD. Preparation of urine samples prior to targeted or untargeted metabolomics mass-spectrometry analysis. Trends Anal Chem. 2012;41: 75-85. doi: 10.1016/j.trac.2012.08.011.
18. Fernie AR, Trethewey RN, Krotzky AJ, Willmitzer L. Metabolite profiling: from diagnostics to systems biology. Nat Rev Mol Cell Biol. 2004;5(9): 763-9. doi: 10.1038/nrm1451.
19. Floegel A, von Ruesten A, Drogan D, Schulze MB, Prehn C, Adamski J, Pischon T, Boeing H. Variation of serum metabolites related to habitual diet: a targeted metabolomic approach in EPIC-Potsdam. Eur J Clin Nutr. 2013;67(10): 1100-8. doi: 10.1038/ejcn.2013.147.
20. Forester SC, Waterhouse AL. Identification of Cabernet Sauvignon anthocyanin gut microflora metabolites. J Agric Food Chem. 2008;56(19): 9299-304. doi: 10.1021/jf801309n.
21. Forester SC, Waterhouse AL. Metabolites are key to understanding health effects of wine polyphenolics. J Nutr. 2009;139(9): 1824S-31. doi: 10.3945/jn.109.107664.
22. Gibney MJ, Walsh M, Brennan L, Roche HM, German B, van Ommen B. Metabolomics in human nutrition: opportunities and challenges. Am J Clin Nutr. 2005;82(3): 497-503.
23. Gika HG, Theodoridis GA, Wilson ID. Liquid chromatography and ultra-performance liquid chromatography- mass spectrometry fingerprinting of human urine: sample stability under different handling and storage conditions for metabonomics studies. J Chromatogr A. 2008;1189(1-2): 314-22. doi: 10.1016/j.chroma.2007.10.066.
24. Gonthier MP, Cheynier V, Donovan JL, Manach C, Morand C, Mila I, Lapierre C, Remesy C, Scalbert A. Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J Nutr. 2003;133(2): 461-7.
25. Grun CH, van Dorsten FA, Jacobs DM, Le Belleguic M, van Velzen EJ, Bingham MO, Janssen HG, van Duynhoven JP. GC-MS methods for metabolic profiling of microbial fermentation products of dietary polyphenols in human and in vitro intervention studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;871(2): 212-9. doi: 10.1016/j.jchromb.2008.04.039.
26. Ismail NA, Posma JM, Frost G, Holmes E, Garcia-Perez I. The role of metabonomics as a tool for augmenting nutritional information in epidemiological studies. Electrophoresis. 2013;34(19): 2776-86. doi: 10.1002/elps.201300066.
27. Issaq HJ, Van QN, Waybright TJ, Muschik GM, Veenstra TD. Analytical and statistical approaches to metabolomics research. J Sep Sci. 2009;32(13): 2183-99. doi: 10.1002/jssc.200900152.
28. Jacobs DM, Deltimple N, van Velzen E, van Dorsten FA, Bingham M, Vaughan EE, van Duynhoven J. (1)H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR Biomed. 2008;21(6): 615-26. doi: 10.1002/nbm.1233.
29. Jacobs DM, Fuhrmann JC, van Dorsten FA, Rein D, Peters S, van Velzen EJ, Hollebrands B, Draijer R, van Duynhoven J, Garczarek U. Impact of short-term intake of red wine and grape polyphenol extract on the human metabolome. J Agric Food Chem. 2012a;60(12): 3078-85. doi: 10.1021/jf2044247.
30. Jacobs DM, Spiesser L, Garnier M, de Roo N, van Dorsten F, Hollebrands B, van Velzen E, Draijer R, van Duynhoven J. SPE-NMR metabolite sub-profiling of urine. Anal Bioanal Chem. 2012b;404(8): 2349-61. doi: 10.1007/s00216-012-6339-2.
31. Jenab M, Slimani N, Bictash M, Ferrari P, Bingham SA. Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet. 2009;125(5-6): 507-25. doi: 10.1007/s00439-009-0662-5.
32. Jimenez-Giron A, Queipo-Ortuno MI, Boto-Ordonez M, Munoz-Gonzalez I, Sanchez-Patan F, Monagas M, Martin-Alvarez PJ, Murri M, Tinahones FJ, Andres-Lacueva C, Bartolome B, Moreno-Arribas MV. Comparative study of microbial-derived phenolic metabolites in human feces after intake of gin, red wine, and dealcoholized red wine. J Agric Food Chem. 2013;61(16): 3909-15. doi: 10.1021/jf400678d.
33. Jones DP, Park Y, Ziegler TR. Nutritional metabolomics: progress in addressing complexity in diet and health. Annu Rev Nutr. 2012;32: 183-202. doi: 10.1146/annurev-nutr-072610-145159
34. Kim K, Mall C, Taylor SL, Hitchcock S, Zhang C, Wettersten HI, Jones AD, Chapman A, Weiss RH. Mealtime, temporal, and daily variability of the human urinary and plasma metabolomes in a tightly controlled environment. PLoS One. 2014;9(1), e86223. doi: 10.1371/journal.pone.0086223.
35. Kussmann M, Raymond F, Affolter M. OMICS-driven biomarker discovery in nutrition and health. J Biotechnol. 2006;124(4): 758-87. doi: 10.1016/j.jbiotec.2006.02.014.
36. Kussmann M, Rezzi S, Daniel H. Profiling techniques in nutrition and health research. Curr Opin Biotechnol. 2008;19(2): 83-99. doi: 10.1016/j.copbio.2008.02.003.
37. Llorach R, Garcia-Aloy M, Tulipani S, Vazquez-Fresno R, Andres-Lacueva C. Nutrimetabolomic strategies to develop new biomarkers of intake and health effects. J Agric Food Chem. 2012;60(36): 8797-808. doi: 10.1021/jf301142b.
38. Llorach-Asuncion R, Jauregui O, Urpi-Sarda M, Andres-Lacueva C. Methodological aspects for metabolome visualization and characterization: a metabolomic evaluation of the 24 h evolution of human urine after cocoa powder consumption. J Pharm Biomed Anal. 2010;51(2): 373-81. doi: 10.1016/j.jpba.2009.06.033.
39. Moco S, Martin FP, Rezzi S. Metabolomics view on gut microbiome modulation by polyphenolrich foods. J Proteome Res. 2012;11(10): 4781-90. doi: 10.1021/pr300581s.
40. Monagas M, Urpi-Sarda M, Sanchez-Patan F, Llorach R, Garrido I, Gomez-Cordoves C, Andres-Lacueva C, Bartolome B. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct. 2010;1(3): 233-53. doi: 10.1039/c0fo00132e.
41. Munoz-Gonzalez I, Jimenez-Giron A, Martin-Alvarez PJ, Bartolome B, Moreno-Arribas MV. Profiling of microbial-derived phenolic metabolites in human feces after moderate red wine intake. J Agric Food Chem. 2013;61(39): 9470-9. doi: 10.1021/jf4025135.
42. Nicholson G, Rantalainen M, Maher AD, Li JV, Malmodin D, Ahmadi KR, Faber JH, Hallgrimsdottir IB, Barrett A, Toft H, Krestyaninova M, Viksna J, Neogi SG, Dumas ME, Sarkans U, The Molpage C, Silverman BW, Donnelly P, Nicholson JK, Allen M, Zondervan KT, Lindon JC, Spector TD, McCarthy MI, Holmes E, Baunsgaard D, Holmes CC. Human metabolic profiles are stably controlled by genetic and environmental variation. Mol Syst Biol. 2011;7: 525. doi: 10.1038/msb.2011.57.
43. Ordovas Munoz JM. Predictors of obesity: the "power" of the omics. Nutr Hosp. 2013;28 Suppl 5: 63-71. doi: 10.3305/nh.2013.28.sup5.6919.
44. Panagiotou G, Nielsen J. Nutritional systems biology: definitions and approaches. Annu Rev Nutr. 2009;29: 329-39. doi: 10.1146/annurev-nutr-080508-141138.
45. Patel KR, Andreadi C, Britton RG, Horner-Glister E, Karmokar A, Sale S, Brown VA, Brenner DE, Singh R, Steward WP, Gescher AJ, Brown K. Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. Sci Transl Med. 2013;5(205): 205133. doi: 10.1126/scitranslmed.3005870.
46. Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012;13(4): 263-9. doi: 10.1038/nrm3314.
47. Primrose S, Draper J, Elsom R, Kirkpatrick V, Mathers JC, Seal C, Beckmann M, Haldar S, Beattie JH, Lodge JK, Jenab M, Keun H, Scalbert A. Metabolomics and human nutrition. Br J Nutr. 2011;105(8): 1277-83. doi: 10.1017/S0007114510004812.
48. Queipo-Ortuno MI, Boto-Ordonez M, Murri M, Gomez-Zumaquero JM, Clemente-Postigo M, Estruch R, Cardona Diaz F, Andres-Lacueva C, Tinahones FJ. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr. 2012;95(6): 1323-34. doi: 10.3945/ajcn.111.027847.
49. Regueiro J, Vallverdu-Queralt A, Simal-Gandara J, Estruch R, Lamuela-Raventos RM. Urinary tartaric acid as a potential biomarker for the dietary assessment of moderate wine consumption: a randomised controlled trial. Br J Nutr. 2014;111(9): 1680-5. doi: 10.1017/S0007114513004108.
50. Renaud SC, Gueguen R, Schenker J, d’Houtaud A. Alcohol and mortality in middle-aged men from eastern France. Epidemiology. 1998;9(2): 184-8.
51. Rotches-Ribalta M, Andres-Lacueva C, Estruch R, Escribano E, Urpi-Sarda M. Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets. Pharmacol Res. 2012a;66(5): 375-82. doi: 10.1016/j.phrs.2012.08.001.
52. Rotches-Ribalta M, Urpi-Sarda M, Llorach R, Boto-Ordonez M, Jauregui O, Chiva-Blanch G, Perez-Garcia L, Jaeger W, Guillen M, Corella D, Tinahones FJ, Estruch R, Andres-Lacueva C. Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method. J Chromatogr A. 2012b;1265: 105-13. doi: 10.1016/j.chroma.2012.09.093.
53. Sanchez-Patan F, Monagas M, Moreno-Arribas MV, Bartolome B. Determination of microbial phenolic acids in human faeces by UPLC-ESI-TQ MS. J Agric Food Chem. 2011;59(6): 2241-7. doi: 10.1021/jf104574z.
54. Sanchez-Patan F, Cueva C, Monagas M, Walton GE, Gibson GR, Quintanilla-Lopez JE, Lebron-Aguilar R, Martin-Alvarez PJ, Moreno-Arribas MV, Bartolome B. In vitro fermentation of a red wine extract by human gut microbiota: changes in microbial groups and formation of phenolic metabolites. J Agric Food Chem. 2012;60(9): 2136-47. doi: 10.1021/jf2040115.
55. Scalbert A, Brennan L, Manach C, Andres-Lacueva C, Dragsted LO, Draper J, Rappaport SM, van der Hooft JJ, Wishart DS. The food metabolome: a window over dietary exposure. Am J Clin Nutr. 2014;99(6): 1286-308. doi: 10.3945/ajcn.113.076133.
56. Smolinska A, Blanchet L, Buydens LM, Wijmenga SS. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta. 2012;750: 82-97. doi: 10.1016/j.aca.2012.05.049.
57. Szekeres T, Fritzer-Szekeres M, Saiko P, Jager W. Resveratrol and resveratrol analogues-structureactivity relationship. Pharm Res. 2010;27(6): 1042-8. doi: 10.1007/s11095-010-0090-1.
58. Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res. 2007;6(2): 469-79. doi: 10.1021/pr060594q.
59. Tulipani S, Llorach R, Urpi-Sarda M, Andres-Lacueva C. Comparative analysis of sample preparation methods to handle the complexity of the blood fluid metabolome: when less is more. Anal Chem. 2013;85(1): 341-8. doi: 10.1021/ac302919t.
60. van Dorsten FA, Grun CH, van Velzen EJ, Jacobs DM, Draijer R, van Duynhoven JP. The metabolic fate of red wine and grape juice polyphenols in humans assessed by metabolomics. Mol Nutr Food Res. 2010;54(7): 897-908. doi: 10.1002/mnfr.200900212.
61. van Velzen EJ, Westerhuis JA, van Duynhoven JP, van Dorsten FA, Grun CH, Jacobs DM, Duchateau GS, Vis DJ, Smilde AK. Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites. J Proteome Res. 2009;8(7): 3317-30. doi: 10.1021/pr801071p.
62. Vazquez-Fresno R, Llorach R, Alcaro F, Rodriguez MA, Vinaixa M, Chiva-Blanch G, Estruch R, Correig X, Andres-Lacueva C. (1)H-NMR-based metabolomic analysis of the effect of moderate wine consumption on subjects with cardiovascular risk factors. Electrophoresis. 2012;33(15): 2345-54. doi: 10.1002/elps.201100646.
63. Vázquez-Fresno R, Llorach R, Urpi-Sarda M, Khymenets O, Bulló M, Corella D, Fitó M, Martínez-González M, Estruch R, Andres-Lacueva C. An NMR metabolomics approach reveals a combined-biomarkers model in a wine interventional trial with validation in freeliving individuals of the PREDIMED study. Metabolomics. 2014;11: 797-806. doi: 10.1007/s11306-014-0735-x.
64. Wishart DS. Advances in metabolite identification. Bioanalysis. 2011;3(15): 1769-82. doi: 10.4155/bio.11.155.
65. Zamora-Ros R, Urpi-Sarda M, Lamuela-Raventos RM, Estruch R, Vazquez-Agell M, Serrano-Martinez M, Jaeger W, Andres-Lacueva C. Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption. Clin Chem. 2006;52(7): 1373-80. doi: 10.1373/clinchem.2005.065870.
66. Zamora-Ros R, Andres-Lacueva C, Lamuela-Raventos RM, Berenguer T, Jakszyn P, Martinez C, Sanchez MJ, Navarro C, Chirlaque MD, Tormo MJ, Quiros JR, Amiano P, Dorronsoro M, Larranaga N, Barricarte A, Ardanaz E, Gonzalez CA. Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Br J Nutr. 2008;100(1): 188-96. doi: 10.1017/S0007114507882997.
67. Zamora-Ros R, Urpi-Sarda M, Lamuela-Raventos RM, Estruch R, Martinez-Gonzalez MA, Bullo M, Aros F, Cherubini A, Andres-Lacueva C. Resveratrol metabolites in urine as a biomarker of wine intake in free-living subjects: the PREDIMED study. Free Radic Biol Med. 2009;46(12): 1562-6. doi: 10.1016/j.freeradbiomed.2008.12.023.
68. Zulyniak MA, Mutch DM. Harnessing metabolomics for nutrition research. Curr Pharm Biotechnol. 2011;12(7): 1005-15.